J2180 HCPCS Level II code: Injection, meperidine and promethazine hcl, up to 50 mg
J2180 is the HCPCS code for “Injection, meperidine and promethazine hcl, up to 50 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J2180Injection, meperidine and promethazine hcl, up to 50 mg
Short description: Meperidine/promethazine inj
HCPCS · United States
Medicare details
The indicators CMS publishes with J2180 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 1982
Where J2180 sits
- 1J codesDrugs administered other than orally
- 2Active code J2180Injection, meperidine and promethazine hcl, up to 50 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J2180 mean?
J2180 is the HCPCS code for “Injection, meperidine and promethazine hcl, up to 50 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J2180?
CMS lists J2180’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J2180
All J codesJ2060Injection, lorazepam, 2 mgJ2062Loxapine for inhalation, 1 mgJ2150Injection, mannitol, 25% in 50 mlJ2151Injection, mannitol, 250 mgJ2170Injection, mecasermin, 1 mgJ2175Injection, meperidine hydrochloride, per 100 mgJ2182Injection, mepolizumab, 1 mgJ2183Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mgJ2184Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mgJ2185Injection, meropenem, 100 mgJ2186Injection, meropenem and vaborbactam, 10mg/10mg (20mg)J2210Injection, methylergonovine maleate, up to 0.2 mg